Express Scripts Inc.
1 Express Way
132 articles with Express Scripts Inc.
To make it simpler for consumers and payers to navigate the hundreds of thousands of currently available personal health technologies and interventions, Express Scripts, a Cigna company, will introduce the industry's first, stand-alone digital health formulary.
Titan Pharmaceuticals Further Expands Patient Access To Probuphine® Via Product Purchase And Supply Agreement With Express Scripts' Specialty Pharmacy, Accredo®
Titan Pharmaceuticals, Inc. announced that it has executed a product purchase and supply agreement with Accredo specialty pharmacy, a subsidiary of Express Scripts, further expanding access to treatment with Probuphine implant, Titan's novel maintenance treatment for Opioid Use Disorder in eligible patients.
Express Scripts, through its commitment to diversity and inclusion, has earned recognition among the Top 50 inclusive companies in the nation by DiversityInc.
Express Scripts and Appriss Health Create New Military Health System Prescription Drug Monitoring Program
New Military Health System PDMP Closes Crucial Information Gap to Improve Safety of Controlled Substances for Military Members and their Families
Accredo, a Full-Service Specialty Pharmacy, Expands Best-in-Class Services with New Pharmacy in Hawaii
Express Scripts announced that its specialty pharmacy, Accredo, will open a new location in Honolulu to provide high-touch pharmacy care to people living with chronic, complex health conditions, such as multiple sclerosis, cancer and hemophilia.
The new program will ensure eligible people with diabetes in participating plans pay no more than $25 for a 30-day supply of insulin.
Cigna and Express Scripts Introduce Patient Assurance Program to Cap Out Of Pocket Costs at $25 per 30-Day Insulin Prescription
Reduces out-of-pocket costs for insulin by 40 percent or more, on average, for many patients
HIMSS ’19: Data-Driven Tools from Cigna and Express Scripts Boost Access to Real-Time Prescription Savings Opportunities
Real-Time Prescription Benefit tool, now available for Cigna health care providers and customers, makes it easier to identify opportunities to decrease out of pocket costs.
Delivered a record low 0.4 percent drug trend across employer-sponsored plans
Last week HHS floated a plan that would allow companies to pass rebates of 26 to 30 percent of a drug’s list price directly to patients in order to be reflected in what consumers pay at the pharmacy counter.
Expensive Drugs Dropped from 2019 Insurance Coverage Cost Up to 95% Less from Verified International Online Pharmacies
More than ninety medications were removed from the formularies of two large pharmacy benefit managers, Express Scripts and Caremark, at the close of 2018.
Cigna Completes Combination with Express Scripts, Establishing a Blueprint to Transform the Health Care System
Cigna with Express Scripts to deliver improved affordability, choice, and predictability through flexible, open and connected solutions
Pet specialty retailer supports commitment to total pet care and wellness with convenient, accessible pet prescriptions available online for doorstep delivery
New National Preferred Flex Formulary provides employers and health plans a pathway to cover lower list price products, help deliver lower member out-of-pocket costs, and reduce reliance on brand rebates.
myMatrixx®, a leader in pharmacy services for workers' compensation programs and a subsidiary of Express Scripts Holding Company (NASDAQ: ESRX), announces the release of myDataSenseSM, an innovative and customizable digital analytics tool that will help drive patient safety and savings.
Express Scripts, a leading pharmacy benefits management company, continues to show its commitment to the region by adding 115 new positions at its Tempe facilities.
Express Scripts Holding Company announced consolidated 2018 third quarter net income of $1,071.6 million or $1.89 per diluted share.
After providing an update of its ongoing strategic review, New York-based Synergy Pharmaceuticals’ stock plunged more than 71 percent.
Thousand Oaks-based Amgen will reduce the price of its anti-cholesterol drug Repatha by 60 percent to $5,850 per year as part of a move to improve affordability by lowering patient copays, the company announced Wednesday.
Express Scripts' Innovative Advanced Opioid Management Solution Shifts First-Time Opioid Users to Safer, Short-Term Prescriptions
Results Align with U.S. Centers for Disease Control & Prevention Recommendations